戻る
Curanex Pharmaceuticals Experiences Post-IPO Share Price Decline Amid Market Scrutiny
戻る
株式ニュース
テーマ
Curanex Pharmaceuticals Experiences Post-IPO Share Price Decline Amid Market Scrutiny
Curanex Pharmaceuticals Experiences Post-IPO Share Price Decline Amid Market Scrutiny
Edgen Stock
·
Sep 28 2025, 08:55
共有先
共有先
リンクをコピー
ソース：
[1] Preclinical biotech Curanex Pharmaceuticals prices IPO at $4, the low end of the range
[2] Curanex Pharmaceuticals' Nasdaq Debut: A Cautious Bet on Botanical Innovation - AInvest
[3] BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering - Stock Titan
Edgen Stock·Sep 28 2025, 08:55Edgen Stock·Sep 28 2025, 08:55
Edgen Stock·Sep 28 2025, 08:55